UK markets closed

Inhibikase Therapeutics, Inc. (IKT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.5950+0.0250 (+1.59%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.67-0.57-2.1-1.45
Low estimate-0.76-0.78-2.33-1.47
High estimate-0.58-0.37-1.87-1.44
Year ago EPS-1.11-0.86-3.57-2.1
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/A260kN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.92-1.12-0.85-0.79
Actual EPS-1.11-0.86-0.64-0.73
Difference-0.190.260.210.06
Surprise %-20.70%23.20%24.70%7.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.67-0.57-2.1-1.45
7 days ago-0.67-0.57-2.1-1.45
30 days ago-0.67-0.57-2.1-1.45
60 days ago-0.67-0.57-2.1-1.45
90 days ago-0.37-0.37-1.77-1.49
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesIKTIndustrySector(s)S&P 500
Current qtr.39.60%N/AN/AN/A
Next qtr.33.70%N/AN/AN/A
Current year41.20%N/AN/AN/A
Next year31.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A